From Nasdaq: 2024-06-13 16:07:15

MarketAxess anticipate the company’s profit to be $13.64 per share in fiscal 2024 and grow 17.1% to $15.98 per share in fiscal 2025. Analyst Carter sees MarketAxess as a compelling investment due to its dominant position in facilitating electronic fixed-income trading, which has seen growing demand amid persisting low interest rates and ongoing market volatility. MarketAxess stock holds a consensus “Moderate Buy” rating overall. Out of the 10 analysts providing recommendations, six suggest a “Strong Buy,” two recommend a “Moderate Buy,” and two advise a “Hold.” www.barchart.com The average analyst price target of $679.22 implies a potential upside of 45.1% from current levels, while the Street-high price target of $730 proposes a potential upside of 55%. Small-cap stocks have faced skepticism with rising interest rates and competition from big names like Nvidia. However, Kornitzer Capital’s Chris Carter believes in the potential of small-cap stocks, highlighting Bio-Techne Corp, Match Group, and MarketAxess as undervalued opportunities aligned with his investment strategy. Bio-Techne’s leadership in life sciences equipment, Match Group’s diverse dating apps, and MarketAxess’s electronic fixed-income trading platform showcase opportunities for growth and resilience.



Read more at Nasdaq: 3 High-Quality Small-Cap Stocks That Investors Are Overlooking